Clinical Trials Directory

Trials / Completed

CompletedNCT02734238

Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery

Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery: a Randomized, Placebo Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
Male
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to determine whether maintaining a eugonadal state, during severe, sustained energy deficit, attenuates physiological decrements, particularly the loss of lean body mass.

Detailed description

This study will enroll up to 60 physically active men in a 3-phase randomized, placebo-controlled trial. After completing a 14-day (free-living, phase 1), energy-adequate, diet-acclimation phase (protein, 1.6 g∙kg-1∙d-1; fat 30% total energy intake, with remaining energy derived from carbohydrate), participants will be randomized to one of two experimental groups and undergo a 28-day (live-in, phase 2), 55% energy deficit phase: energy deficit alone (DEF) or energy deficit + exogenous testosterone (DEF+TEST). Recovery (free-living, phase 3) will be assessed after completing phase 2 to determine when body mass has been recovered within ± 2.5% of initial body mass (duration will vary, 42-day maximum for phase 3). This study will delineate the contribution of testosterone declines from the physical and mental demands encountered by Warfighters during military training and combat operations on complex markers of physiological and psychological status, addressing a direct, consistently observed, gap in knowledge.

Conditions

Interventions

TypeNameDescription
DRUGSesame Oil200 mg sesame oil by intramuscular injection weekly on days 15, 21, 28, and 35
DRUGtestosterone enanthate200 mg testosterone enanthate by intramuscular injection weekly on days 15, 21, 28, and 35

Timeline

Start date
2016-04-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-04-12
Last updated
2019-01-16
Results posted
2019-01-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02734238. Inclusion in this directory is not an endorsement.